policy
Regenerative medicine, including therapeutic use of stem cells
Regenerative medicine holds promise in treating a variety of diseases, yet questions remain. The AVMA supports the continued scientific development of…
policy
Guidelines for use of exempt biologics
State-licensed veterinarians may consider preparing biologics in their practice facility under a VCPR in unique disease situations not adequately…
policy
Development of emerging disease agent biologics
Development of emerging infectious disease biologics is essential for One Health. The AVMA supports the development of these products through…
AVMA news
USDA starts highly pathogenic avian influenza vaccine trials
In April, the U.S. Department of Agriculture (USDA) began testing the efficacy of four vaccines against highly pathogenic avian influenza (HPAI).…
AVMA news
AVMA editor-in-chief becomes Equine Research Hall of Famer, with three others
AVMA Editor-In-Chief Lisa Fortier along with Drs. Katrin Hinrichs, Jennifer Anne Mumford, and Stephen M. Reed are this year’s inductees into the…
JAVMA news
Candidate vaccine protects pigs against African swine fever strains
A U.S. Department of Agriculture–developed vaccine against African swine fever protected pigs in a second study, suggesting progress toward a…
JAVMA news
Racing to save humans through animal research
Veterinary researchers are improving our understanding of the SARS-CoV-2 virus, interspecies transmission, and a host of other public and animal…